Skip to main content
logo
Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.26
-0.24 (-3.20%)
At close: Jul 24, 2026, 4:00 PM EDT
7.21
-0.05 (-0.69%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Commercial Products
226.10M398.90M497.30M386.60M438.00M
Mcm Products
456.70M509.80M447.20M579.60M585.90M
Other
60.10M134.90M104.80M--
Services
---109.90M615.50M
Unallocated Contracts and Grants
---41.40M134.20M
Total
742.90M1.04B1.05B1.12B1.77B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
531.10M822.60M607.20M886.10M1.62B
Canada
75.00M140.40M224.20M148.60M66.70M
Other
136.80M80.60M217.90M82.80M83.50M
Total
742.90M1.04B1.05B1.12B1.77B